🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to gather feedback on a new continuous glucose...
Status
Completed
Location
Sheffield Teaching Hospital NHS Foundation Trust
Start Date
2022-08-10
Trial ID
NCT05453344
Treatments Being Tested
Parkinson's disease (PD) affects over 10 million worldwide, causing unstabl...
Status
Recruiting
Location
Tel-Aviv Sourasky Medical Center
Start Date
2025-03-31
Trial ID
NCT07105787
Treatments Being Tested
Sleep and particularly deep sleep are playing an important role for brain a...
Status
Completed
Location
ETH Zurich
Start Date
2020-01-13
Trial ID
NCT04166916
Treatments Being Tested
The purpose of this study is to find the number of natural killer (NK) cell...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2018-05-22
Trial ID
NCT02890758
Treatments Being Tested
Marijuana remains the most prevalent illicit substance used by adolescents ...
Status
Completed
Location
Geisel School of Medicine at Dartmouth
Start Date
2007-11
Trial ID
NCT00580671
This is a multicentric, prospective, intervention study on circadian genes ...
Status
Unknown
Location
Department of Experimental Medicine, "Sapienza" University of Rome
Start Date
2018-07-04
Trial ID
NCT04374721
Treatments Being Tested
Sodium (Na+) hemostasis is abnormal in CKD patients, and this element can b...
Status
Recruiting
Location
LHSC Regional Renal Care Program
Start Date
2018-03-05
Trial ID
NCT03004547
Treatments Being Tested
The goals of this clinical research are to evaluate the outcomes and tumor ...
Status
Terminated
Location
UPMC Shadyside Radiation Oncology Department
Start Date
2011-04
Trial ID
NCT02067858
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2017-05-12
Trial ID
NCT03134638